Heart Attack Risk of Testosterone Drugs Under U.S. Review
This article is for subscribers only.
Testosterone drugs are getting a closer look from U.S. regulators after two separate studies found an increased risk of heart attack, stroke and death in men who took the therapies.
The Food and Drug Administration said in a statement today that it will review the safety risk of testosterone drugs to see whether they increase the possibility of such harm. The agency said it has been evaluating the risk of the treatments and decided to reassess its analysis given the recent data.